Fresenius Medical Care AG reports developments in kidney care, dialysis services, and dialysis products for individuals with renal disease. Company news commonly covers Care Delivery clinic operations, Care Enablement products such as dialysis machines, dialyzers, and the 5008X CAREsystem, and Value-Based Care activity, along with organic revenue, operating income, margins, leverage, and share buyback updates.
Other recurring items include portfolio optimization, research in hemodiafiltration, artificial intelligence and digital tools for nephrology, and governance changes affecting the Management Board and Supervisory Board. Updates also describe the company's Frankfurt and New York listings and shareholder matters tied to its ordinary shares and ADRs.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Fresenius Kidney Care has launched a pioneering home dialysis training program at its Indianapolis Shadeland Station, aimed at facilitating a smooth transition for patients moving from in-center treatment to home therapy. The program prioritizes community building among patients and offers tailored training with dedicated care teams. Wendy Taylor, Home Therapy Clinic Manager, highlighted the program’s efficiency in getting both hemodialysis and peritoneal dialysis patients ready for home therapy. Since its inception in January 2023, two patients have successfully transitioned to home dialysis, enhancing their treatment autonomy and quality of life.